PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Algorithmiq secures USD4m in seed funding from angel syndicate

Algorithmiq has raised USD4 million in seed funding round to make its quantum-enhanced drug discovery platform commercially available.

Algorithmiq has raised USD4 million in seed funding round to make its quantum-enhanced drug discovery platform commercially available.

The investors include Jorma Ollila (Nokia/Shell), Haakon Overli (Dawn Capital), Thames Trust (Lord Jim O’Neill), David Helgason (Foobar/Unity3D), Tiger Global, Feroz Dewan (Arena Holdings), Keenan Rice (Tokyo Black/LookerGoogle/Firebolt) and K5 Global and other European and US angels and entrepreneurs. 

Algorithmiq can boost the speed of chemical simulations on quantum computers by a factor of 100-times compared to current industry benchmarks and expands the universe of chemical simulations tractable on near-term quantum devices.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured